How Analysts Rated Halyard Health, Inc. (NYSE:HYH) Last Week?

December 8, 2017 - By Peter Erickson

 How Analysts Rated Halyard Health, Inc. (NYSE:HYH) Last Week?

Halyard Health, Inc. (NYSE:HYH) Ratings Coverage

Among 7 analysts covering Halyard Health Inc (NYSE:HYH), 3 have Buy rating, 1 Sell and 3 Hold. Therefore 43% are positive. Halyard Health Inc had 18 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Halyard Health, Inc. (NYSE:HYH) earned “Sector Weight” rating by KeyBanc Capital Markets on Friday, December 18. Stephens upgraded the stock to “Overweight” rating in Thursday, August 3 report. As per Monday, October 12, the company rating was downgraded by Morgan Stanley. The firm has “Buy” rating by Stifel Nicolaus given on Wednesday, January 27. The stock has “Hold” rating by KeyBanc Capital Markets on Tuesday, October 17. The stock has “Overweight” rating by Stephens on Friday, April 8. The stock has “Buy” rating by Deutsche Bank on Wednesday, August 10. Raymond James initiated Halyard Health, Inc. (NYSE:HYH) on Tuesday, July 21 with “Market Perform” rating. Stifel Nicolaus maintained Halyard Health, Inc. (NYSE:HYH) rating on Wednesday, August 2. Stifel Nicolaus has “Buy” rating and $4500 target. The stock has “Buy” rating by Stifel Nicolaus on Monday, September 18. Below is a list of Halyard Health, Inc. (NYSE:HYH) latest ratings and price target changes.

17/10/2017 Broker: KeyBanc Capital Markets Rating: Hold Maintain
18/09/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $45.0 Maintain
03/08/2017 Broker: Deutsche Bank Rating: Buy Old Target: $35 New Target: $42 Maintain
03/08/2017 Broker: Stephens Old Rating: Equal-Weight New Rating: Overweight Upgrade
02/08/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $45.0000 Maintain

The stock decreased 1.15% or $0.55 during the last trading session, reaching $47.12. About 341,173 shares traded. Halyard Health, Inc. (NYSE:HYH) has risen 28.46% since December 8, 2016 and is uptrending. It has outperformed by 11.76% the S&P500.

Halyard Health, Inc. operates as a medical technology firm that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. The company has market cap of $2.21 billion. The firm operates through two divisions, Medical Devices and Surgical and Infection Prevention . It has a 39.23 P/E ratio. The Medical Devices segment provides a portfolio of products that focuses on pain management, and respiratory and digestive health to enhance patient outcomes.

More notable recent Halyard Health, Inc. (NYSE:HYH) news were published by: Nasdaq.com which released: “Phocas Financial Corp. Buys Halyard Health Inc, Sabra Health Care REIT Inc …” on November 17, 2017, also Prnewswire.com with their article: “Halyard Health, Inc. to Present at Stifel 2017 Healthcare Conference” published on November 01, 2017, Seekingalpha.com published: “Halyard Health’s (HYH) Management Presents at Stifel Nicolaus Health Care …” on November 15, 2017. More interesting news about Halyard Health, Inc. (NYSE:HYH) were released by: Seekingalpha.com and their article: “Halyard Health: Is A Major Divestiture In The Works?” published on June 30, 2017 as well as Reuters.com‘s news article titled: “Halyard Health explores sale of hospital product unit: sources” with publication date: June 12, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: